FIELD: medicine.
SUBSTANCE: invention deals with application of alkyl phospholipids with lower cytotoxicity for obtaining medication for treating diseases and/or pathophysiological conditions in mammals caused by fungi.
EFFECT: medication possesses wide spectrum of action.
4 cl, 13 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS | 2016 |
|
RU2734877C2 |
ANTIMICROBIAL PEPTIDES CONTAINING ARGININE- AND LYSINE-CONTAINING MOTIVE | 2005 |
|
RU2396273C2 |
MYCOBACTERIUM TUBERCULOSIS VACCINE | 2009 |
|
RU2473365C1 |
SYNTHETIC GLUCOPYRANOSYL LIPOID ADJUVANTS | 2010 |
|
RU2732574C2 |
SYNTHETIC GLUCOPYRANOSYLLIPID ADJUVANTS | 2010 |
|
RU2560182C2 |
USE OF PARASITES AND EXTRACELLULAR VESICLES DERIVED FROM PARASITES FOR TREATING MALIGNANT TUMOUR | 2020 |
|
RU2814990C2 |
THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | 2018 |
|
RU2790011C2 |
AROMATIC COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATING AND ANTIPROLIFERATIVE AGENTS | 2003 |
|
RU2386625C2 |
IMMUNOSTIMULATING NUCLEIC ACIDS | 2000 |
|
RU2245149C2 |
CONJUGATES AND COMPOSITIONS FOR IMMUNOTHERAPY AND ANTICANCER TREATMENT | 2010 |
|
RU2597989C2 |
Authors
Dates
2012-12-20—Published
2006-12-19—Filed